Skip to content

Clinical trials

Phase 1 Leukemia, Myeloid, Acute trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1 Country / region: Japan Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20112
20123
20131
20143
20151
20164
20172
20184
20203
20212
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated9
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Otsuka Pharmaceutical Co., Ltd.4
Amgen3
Daiichi Sankyo Co., Ltd.3
Novartis Pharmaceuticals3
Astellas Pharma Inc1
AstraZeneca1
Boehringer Ingelheim1
Celgene Corporation1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute30
Myelodysplastic Syndromes8
Neoplasms7
Lymphoma, Non-Hodgkin6
Hematologic Neoplasms5
Multiple Myeloma5
Recurrence3
Leukemia, Myelomonocytic, Chronic2
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.